Login
Home
Charts
Search
Watchlist
Products

JHS Svendgaard Laboratories Ltd

JHS·NSE
8.47+1.56%Wed, 23 Sept '26

JHS Svendgaard Laboratories Ltd

JHS
NSE
8.47
+1.56%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
74Cr
Close
Close Price
8.47
Industry
Industry
Personal Care
PE
Price To Earnings
PS
Price To Sales
0.68
Revenue
Revenue
109Cr
Rev Gr TTM
Revenue Growth TTM
19.43%
PAT Gr TTM
PAT Growth TTM
89.53%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
191422242023252322233330
Growth YoY
Revenue Growth YoY%
-10.1-35.6-0.354.04.058.516.2-4.213.22.729.929.6
Expenses
ExpensesCr
191421232122312221223428
Operating Profit
Operating ProfitCr
0012-10-5212-22
OPM
OPM%
2.2-0.33.88.0-4.31.1-21.47.14.17.2-5.06.8
Other Income
Other IncomeCr
021010-111110
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
-1100-2-2-9100-30
Tax
TaxCr
011180-200-11-1
PAT
PATCr
-10-1-1-10-2-7101-41
Growth YoY
PAT Growth YoY%
20.6100.493.075.7-1,313.7-18,500.0-828.0268.398.1142.948.72.8
NPM
NPM%
-3.90.1-3.5-2.6-52.4-8.1-27.64.5-0.93.4-10.93.6
EPS
EPS
-0.10.0-0.1-0.1-1.2-0.2-0.80.10.00.1-0.40.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
191422242023252322233330
Growth YoY
Revenue Growth YoY%
-10.1-35.6-0.354.04.058.516.2-4.213.22.729.929.6
Expenses
ExpensesCr
191421232122312221223428
Operating Profit
Operating ProfitCr
0012-10-5212-22
OPM
OPM%
2.2-0.33.88.0-4.31.1-21.47.14.17.2-5.06.8
Other Income
Other IncomeCr
021010-111110
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
-1100-2-2-9100-30
Tax
TaxCr
011180-200-11-1
PAT
PATCr
-10-1-1-10-2-7101-41
Growth YoY
PAT Growth YoY%
20.6100.493.075.7-1,313.7-18,500.0-828.0268.398.1142.948.72.8
NPM
NPM%
-3.90.1-3.5-2.6-52.4-8.1-27.64.5-0.93.4-10.93.6
EPS
EPS
-0.10.0-0.1-0.1-1.2-0.2-0.80.10.00.1-0.40.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
10010514012413910186857192102109
Growth
Revenue Growth%
80.95.033.5-11.612.2-27.6-14.4-1.7-16.529.910.519.4
Expenses
ExpensesCr
9493127125137998794729699106
Operating Profit
Operating ProfitCr
61214-122-1-9-1-433
OPM
OPM%
6.411.19.8-0.51.21.9-1.0-10.7-1.3-4.42.62.8
Other Income
Other IncomeCr
-40327389-74033
Interest Expense
Interest ExpenseCr
011121110111
Depreciation
DepreciationCr
1067797766887
PBT
PBTCr
-22538-2-610-23-3-13-2-3
Tax
TaxCr
0-17120-104-5170-1
PAT
PATCr
-222226-2-51-4-18-4-20-2-2
Growth
PAT Growth%
2.4201.418.8-106.4-191.2127.7-419.5-308.476.8-386.690.389.5
NPM
NPM%
-21.620.918.6-1.3-3.51.3-5.0-20.6-5.7-21.5-1.9-1.7
EPS
EPS
-8.35.44.5-0.1-0.30.2-0.6-2.3-0.5-2.4-0.2-0.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
10010514012413910186857192102109
Growth
Revenue Growth%
80.95.033.5-11.612.2-27.6-14.4-1.7-16.529.910.519.4
Expenses
ExpensesCr
9493127125137998794729699106
Operating Profit
Operating ProfitCr
61214-122-1-9-1-433
OPM
OPM%
6.411.19.8-0.51.21.9-1.0-10.7-1.3-4.42.62.8
Other Income
Other IncomeCr
-40327389-74033
Interest Expense
Interest ExpenseCr
011121110111
Depreciation
DepreciationCr
1067797766887
PBT
PBTCr
-22538-2-610-23-3-13-2-3
Tax
TaxCr
0-17120-104-5170-1
PAT
PATCr
-222226-2-51-4-18-4-20-2-2
Growth
PAT Growth%
2.4201.418.8-106.4-191.2127.7-419.5-308.476.8-386.690.389.5
NPM
NPM%
-21.620.918.6-1.3-3.51.3-5.0-20.6-5.7-21.5-1.9-1.7
EPS
EPS
-8.35.44.5-0.1-0.30.2-0.6-2.3-0.5-2.4-0.2-0.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3844616161646578788687
Reserves
ReservesCr
578611311611712412195918587
Current Liabilities
Current LiabilitiesCr
1820323948231937232533
Non Current Liabilities
Non Current LiabilitiesCr
212287818448
Total Liabilities
Total LiabilitiesCr
121155208221241228222228197201215
Current Assets
Current AssetsCr
36431031021301217985445463
Non Current Assets
Non Current AssetsCr
85113105120111107143143153147152
Total Assets
Total AssetsCr
121155208221241228222228197201215
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
3844616161646578788687
Reserves
ReservesCr
578611311611712412195918587
Current Liabilities
Current LiabilitiesCr
1820323948231937232533
Non Current Liabilities
Non Current LiabilitiesCr
212287818448
Total Liabilities
Total LiabilitiesCr
121155208221241228222228197201215
Current Assets
Current AssetsCr
36431031021301217985445463
Non Current Assets
Non Current AssetsCr
85113105120111107143143153147152
Total Assets
Total AssetsCr
121155208221241228222228197201215

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-4-414-111012-923-9-5-3
Investing Cash Flow
Investing Cash FlowCr
1-3-27-7-11-2-510-21-20-12
Financing Cash Flow
Financing Cash FlowCr
4101413010-2-122311
Net Cash Flow
Net Cash FlowCr
230-5020-1632-28-2-3
Free Cash Flow
Free Cash FlowCr
-7-173-2604-169-41-15
CFO To PAT
CFO To PAT%
17.4-17.953.0647.1-213.2896.1213.0-132.9226.226.2138.5
CFO To EBITDA
CFO To EBITDA%
-58.6-33.6100.41,833.6619.0627.01,086.2-256.7979.2129.1-101.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-4-414-111012-923-9-5-3
Investing Cash Flow
Investing Cash FlowCr
1-3-27-7-11-2-510-21-20-12
Financing Cash Flow
Financing Cash FlowCr
4101413010-2-122311
Net Cash Flow
Net Cash FlowCr
230-5020-1632-28-2-3
Free Cash Flow
Free Cash FlowCr
-7-173-2604-169-41-15
CFO To PAT
CFO To PAT%
17.4-17.953.0647.1-213.2896.1213.0-132.9226.226.2138.5
CFO To EBITDA
CFO To EBITDA%
-58.6-33.6100.41,833.6619.0627.01,086.2-256.7979.2129.1-101.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8517332716846128133102128965674
Price To Earnings
Price To Earnings
-3.97.912.5105.030.2-28.9
Price To Sales
Price To Sales
0.81.62.31.40.31.31.61.21.81.00.60.7
Price To Book
Price To Book
0.91.31.90.90.30.70.70.70.80.60.30.4
EV To EBITDA
EV To EBITDA
12.914.323.4-293.731.659.6-158.2-7.3-131.5-20.619.722.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.026.826.621.720.621.418.913.523.819.4
OPM
OPM%
6.411.19.8-0.51.21.9-1.0-10.7-1.3-4.42.62.8
NPM
NPM%
-21.620.918.6-1.3-3.51.3-5.0-20.6-5.7-21.5-1.9-1.7
ROCE
ROCE%
-22.14.422.3-0.6-2.11.10.8-12.7-1.7-6.8-0.8-0.8
ROE
ROE%
-22.916.914.9-0.9-2.70.7-2.3-10.1-2.4-11.6-1.1-1.1
ROA
ROA%
-17.914.112.5-0.8-2.00.6-1.9-7.7-2.1-9.8-0.9-0.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
8517332716846128133102128965674
Price To Earnings
Price To Earnings
-3.97.912.5105.030.2-28.9
Price To Sales
Price To Sales
0.81.62.31.40.31.31.61.21.81.00.60.7
Price To Book
Price To Book
0.91.31.90.90.30.70.70.70.80.60.30.4
EV To EBITDA
EV To EBITDA
12.914.323.4-293.731.659.6-158.2-7.3-131.5-20.619.722.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
20.026.826.621.720.621.418.913.523.819.4
OPM
OPM%
6.411.19.8-0.51.21.9-1.0-10.7-1.3-4.42.62.8
NPM
NPM%
-21.620.918.6-1.3-3.51.3-5.0-20.6-5.7-21.5-1.9-1.7
ROCE
ROCE%
-22.14.422.3-0.6-2.11.10.8-12.7-1.7-6.8-0.8-0.8
ROE
ROE%
-22.916.914.9-0.9-2.70.7-2.3-10.1-2.4-11.6-1.1-1.1
ROA
ROA%
-17.914.112.5-0.8-2.00.6-1.9-7.7-2.1-9.8-0.9-0.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — JHS Svendgaard Laboratories Ltd

  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/nq4zvkz533g5emyh720s5awc.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/qxp7a3030nc3chfgya46nsrb.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/o5km720p7or96m62pi89pj6d.pdf
  • Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/mptc32mdgg3i0iiqfy6jcci0.pdf
  • Q4 FY2022 Earnings Call Transcript (Mar 2022, PDF): https://www.stockscans.in/document/xjaca2xu7sms2nqnw8acdflw.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/a6profypuntww7uf4eq1k68s.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/qloeoyo7zp6wbpvlcd19qy4c.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/moda8fvh2tkgp7lhhgczxgam.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/phidp918w4x2uu1eysa2te6e.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/jdguky9sy7f1cby3jxcsrp6o.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/voyjmynz4174dqj3qfni3xwx.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/upywccw41o0t2o5dwrdte9b0.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/oi6vcviikvyza7xbgkh4w1td.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/irwsuf7ibw86dvt733mgwm2o.pdf
  • Q2 FY2024 Investor Presentation (Sep 2023, PDF): https://www.stockscans.in/document/qrx9uqwgql0eweim6p9fspzc.pdf
  • Q4 FY2023 Investor Presentation (Mar 2023, PDF): https://www.stockscans.in/document/0equ6kni03qv1yroxnvzqxxl.pdf
  • Q2 FY2023 Investor Presentation (Sep 2022, PDF): https://www.stockscans.in/document/r6yad7rvgez3ejn6oxaksxxh.pdf
  • Q1 FY2023 Investor Presentation (Jun 2022, PDF): https://www.stockscans.in/document/n731ta4fiur7qeyeqgpe9la7.pdf
  • Q4 FY2022 Investor Presentation (Mar 2022, PDF): https://www.stockscans.in/document/jpw0o6l087upthlklfd2luzs.pdf
  • Q3 FY2022 Investor Presentation (Dec 2021, PDF): https://www.stockscans.in/document/qqbzcu8hohebo8gwlsr7am4y.pdf
  • Q2 FY2022 Investor Presentation (Sep 2021, PDF): https://www.stockscans.in/document/2nfb0ehs2ld7uoxpmzsxko34.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/76g8jswlbrs4o7c3lt6e46q5.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/dr5jouukgzjyytcbfp9simlw.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/kulydp15pmpm4rk74eb15u94.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/1ilc2prf3pi9ia8snaq51p5u.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/ejctnpijwr530u0a49gfyrew.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/qnt3jpi7xgmxxvckonixy7n8.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/jjkkxiyzhpmcprke1b4rhw8q.pdf

Concall Transcript Summaries — JHS Svendgaard Laboratories Ltd

  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3AJHS/transcript-notes/202403/nq4zvkz533g5emyh720s5awc.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3AJHS/transcript-notes/202309/qxp7a3030nc3chfgya46nsrb.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3AJHS/transcript-notes/202303/o5km720p7or96m62pi89pj6d.pdf
  • Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/NSE%3AJHS/transcript-notes/202209/mptc32mdgg3i0iiqfy6jcci0.pdf